Triton Fundus Autofluorescence and Fluorescein Angiography
NCT ID: NCT03107104
Last Updated: 2022-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
47 participants
OBSERVATIONAL
2017-03-30
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Topcon DRI OCT Triton With SS-OCT Angio Software Evaluation Study
NCT04201340
OCT Image Quality Performance Evaluation
NCT02991027
Clinical Validation of New OCT System
NCT01809704
Evaluation of the Signal to Noise Ratio at Various Retinal Layers
NCT02982174
Triton Reference Database
NCT03067675
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Compare the image quality of the fundus autofluorescence (FAF) photographs between DRI OCT Triton (plus) and TRC-50DX retinal camera.
2. Compare the image quality of the fluorescein angiography (FA) photographs between DRI OCT Triton (plus) and TRC-50DX retinal camera.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Medical need for FA imaging
Subjects deemed to have a medical need for FA imaging will be imaged on the Topcon DRI OCT Triton (plus) and TRC-50DX retinal camera
Topcon DRI OCT Triton (plus)
The Topcon DRI OCT Triton (plus) is an OCT with a fundus camera used for diagnostic purposes
TRC-50DX retinal camera
The TRC-50DX retinal camera is a fundus camera used for diagnostic purposes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Topcon DRI OCT Triton (plus)
The Topcon DRI OCT Triton (plus) is an OCT with a fundus camera used for diagnostic purposes
TRC-50DX retinal camera
The TRC-50DX retinal camera is a fundus camera used for diagnostic purposes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects able to understand the written informed consent and willing to participate as evidenced by signing the informed consent
3. Subjects who consent to, via clinic's standard FA consent form, and will undergo dye injection for FA imaging at the clinic visit based on medical need
Exclusion Criteria
2. Subjects with ocular media not sufficiently clear to obtain acceptable fundus images
3. Patients with ocular motility dysfunction
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Topcon Medical Systems, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charles Riesman, MS
Role: STUDY_CHAIR
Topcon Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vitreous Retina Macula Consultants of New York
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Triton FA FAF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.